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Abstract
Hedgehog (Hh) signalling is a potent regulator of cell fate and function. While much is
known about the events within a Hh-stimulated cell, far less is known about the regulation
of Hh-ligand production. Drosophila Hyperplastic Discs (Hyd), a ubiquitin-protein ligase,
represents one of the few non-transcription factors that independently regulates both hh
mRNA expression and pathway activity. Using a murine embryonic stem cell system, we
revealed that shRNAi of the mammalian homologue of hyd, Ubr5, effectively prevented
retinoic-acid-induced Sonic hedgehog (Shh) expression. We next investigated the UBR5:
Hh signalling relationship in vivo by generating and validating a mouse bearing a condi-
tional Ubr5 loss-of-function allele. Conditionally deleting Ubr5 in the early embryonic limb-
bud mesenchyme resulted in a transient decrease in Indian hedgehog ligand expression
and decreased Hh pathway activity, around E13.5. Although Ubr5-deficient limbs and dig-
its were, on average, shorter than control limbs, the effects were not statistically signifi-
cant. Hence, while loss of UBR5 perturbed Hedgehog signalling in the developing limb,
there were no obvious morphological defects. In summary, we report the first conditional
Ubr5mutant mouse and provide evidence for a role for UBR5 in influencing Hh signalling,
but are uncertain to whether the effects on Hedgehog signaling were direct (cell autono-
mous) or indirect (non-cell-autonomous). Elaboration of the cellular/molecular mechanism
(s) involved may help our understanding on diseases and developmental disorders asso-
ciated with aberrant Hh signalling.
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Introduction
In multicellular organisms Hedgehog (Hh) morphogens play an essential role in tissue/organ
development [1] and their subsequent maintenance [2]. Acting as an extracellular signalling
molecule, Hh ligands signal in a predominantly paracrine manner to convey information to
neighbouring cells. Tight regulation of Hh ligand expression ensures temporal-spatial genera-
tion of morphogen gradients, which in turn ensure a well co-ordinated and appropriate cellular
response [3]. The importance of correct Hh expression patterns is clear from the numerous
human diseases (e.g., gastrointestinal, pancreatic and skin cancers) [4] and developmental dis-
orders (e.g., cyclopia, cleft lip and limb abnormalities) [5] that result from its misexpression.
Mammals express three Hh ligands (Sonic-, Indian and Desert-Hedgehog) that exhibit dis-
tinct expression patterns throughout the body (EMBL Expression Atlas). Engagement of Hh
ligands with one of their receptors Patched (Ptch1) [6–8] results in derepression of the Hedge-
hog signal transduction pathway, activation of the GLI family zinc finger (GLI) family of tran-
scription factors and the subsequent transcription of GLI target genes. Activation of the Hh
pathway (HhP) influences a wide range of cellular responses that include promotion of prolif-
eration, differentiation and suppression of apoptosis[1]. Hedgehog signalling affects cell behav-
iour in multiple tissues and is heavily implicated in the communication between cells,
including adult stem cells and their niches[2].
A large body of work has focused on investigating Sonic hedgehog (Shh) expression and
function during animal development, with a particular focus on the developing limb[9]. Within
the embryonic limb bud, Shh expression is spatially restricted to a posteriorly located zone of
polarising activity (ZPA)[10], where its expression is regulated by a long-range enhancer ele-
ment called the zone of polarizing activity regulatory sequence (ZRS) [11]. SHH expression
within the ZPA, and its subsequent diffusion/transport across the tissue, sets up a posterior-
anterior morphogen gradient that acts to instruct distinct cell fates and govern digit formation
[9]. A number of human disease-associated point mutations within, or chromosomal translo-
cations affecting, Shh’s regulatory regions underlie deregulated SHH/Shh expression and digit
abnormalities [12].
While the molecular details concerning Shh DNA regulatory elements are well-described
[13], far less is known about the proteins and upstream signalling pathway(s) that regulate Shh
expression. In mammals Ras-associated signalling appears to promote Shh expression [14],
while in Drosophila, Hyperplastic Disc (Hyd) suppresses hh ligand expression [15, 16]. Mecha-
nistically, Hyd appears to regulate hh expression through influencing Shaggy–the Drosophila
ortholog of Glycogen synthase kinase β (GSK3β) [16]. The ability of Hyd and its human ortho-
log E3 identified by Differential Display (EDD) to bind GLI2 [16], one of the HhP’s major tran-
scriptional effectors, potentially places Hyd/EDD both upstream and downstream of the
Hedgehog ligand activity. Here, we addressed whether Hyd’s murine homologue Ubiquitin
Protein Ligase E3 Component N-recognin 5 (UBR5) could also influence Hedgehog pathway
activity and ligand expression.
UBR5 contains a number of domains related to ubiquitin signalling, which include a Ubi-
quitin binding domain (UBA) [17], a substrate recruitment domain for N-end rule substrates
called the Ubiquitin-protein ligase E3 component N-Recognin (UBR) domain [18, 19] and a
catalytic Homologous to E6AP C-terminus (HECT) domain [20]–the presence of which
defines UBR5 as an E3 ubiquitin-protein ligase. Functionally, UBR5 has previously been linked
to DNA damage signalling [21–23], miRNA activity [24], metabolism [25] and cell cycle check-
point control [26–30].
Our data supports a potential role for UBR5 in influencing hedgehog family member ligand
expression and HhP activity, although we are unclear about the mechanism.
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Materials and Methods
mES 14 cell culture and retinoic acid treatment
E14 mouse embryonic stem (mES) cells were cultured on 0.1% porcine gelatin (Sigma) coated
6-well plates at 37°C and 5% CO2 in GMEM (Invitrogen) supplemented with 10% foetal bovine
serum, 103 U/ml leukaemia inhibitory factor (Millipore). Retinoic acid (Sigma) or DMSO
(Sigma) vehicle was added to the media and refreshed every 24 hours.
shRNAi transfection and selection
6-well plates containing 2x106 cells in antibiotic-free GMEM were transfected with 4μg of
pLKO-based, puromycin-expressing, Ubr5 shRNAi constructs (Sigma MISSION,
TRCN0000003411 (Ubr5.1), TRCN0000226458 (Ubr5.2) and TRCN0000238587 (Ubr5.3) with
Effectene (Qiagen) as per the manufacturer’s instruction. 24 hours later, transfected cells were
selected in 0.1μg/ml puromycin (Sigma) and resistant colonies were pooled.
RNA extraction, reverse transcription and PCR
RNA was extracted from embryos, dissected limb buds or ES cells using QIAshredder homoge-
nisers coupled with RNeasy kits (QIAGEN) as per the manufacturers instructions. cDNA was
produced using a First Strand cDNA Synthesis Kit also as per manufacturer’s instructions
(Roche). All semi-quantitative RT-PCR was carried out using Platinum Taq Polymerase PCR
kit (Invitrogen) using a MJ Research Tetrad PTC-225 PCR machine. Primers used: Shh For
GCC TAC AAG CAG TTT ATT CCC AAC and Rev CAG TGG ATG TGA GCT TTG GAT
TC; Ubr5 For CTC GAG GAA AGC TAG AGC AAA AAA TAA AAA GCC CAA ATC CAG
and Rev GAG CTC TAC AGC GAC ATA GGC ACC ATC TAC C; β-actin For GGC CCA
GAG CAA GAG AGG TAT CC and Rev ACG CAC GAT TTC CCT CTC AGC; Nanog For
ACC TGA GCT ATA AGC AGG TTA AGA C and Rev GTG CTG AGC CCT TCT GAA TCA
GAC; Bmp4 For GAG GAG TTT CCA TCA CGA AGA and REV GCT CTG CCG AGG AGA
TCA; Klf4 For CCA GCAAGT CAG CTT GTG AA and Rev GGG CATGTT CAAGTT GGA
TT. Quantitative RT-PCR (qRT-PCR) was carried out using the Roche Universal probe Library
coupled with the Lightcycler1480 system as per manufacturer’s instructions (Roche). Gene spe-
cific assays were designed using the online Assay Design Centre Tool (www.universalprobelibrary.
com): Shh For ACC CCGACA TCA TAT TTA AGGA and Rev TTA ACT TGT CTT TGCACC
TCT GA (UPL probe 32);Ubr5 For TCA GCT CGAAGAGAGAGGATG and Rev GCT CAG
CAA TGT AGCACG TC (UPL probe 103). The β-actin control reagent master mix was used to
generate an internal reference for all reactions. Relative expression levels were determined using
the ΔCt model [31].
SDS-PAGE andWestern blotting
Cells and dissected limb buds were lysed in a 1%TX-100 lysis buffer and processed as described
previously [32]. For the limb buds, cytoplasmic and nuclear fractions were separated using
NE-PER1 nuclear and cytoplasmic protein extraction kit (Thermo Scientific). Proteins (30μg)
were resolved by SDS-PAGE using 3–8% Tris-acetate gradient gels with Tris-acetate Running
Buffer (Invitrogen) and wet-blotted onto PVDF membrane (Millipore) overnight at 4°C using
Towbin buffer. Membranes were blocked in 5% milk/PBS at room temperature (RT) for one
hour and incubated with primary antibodies against: UBR5 (Santa Cruz goat EDDM-19
1:2500); β-tubulin (Sigma mouse 1:30,000) and HP-1 (Chemicon mouse 1:10,000) for one hour
at RT in 0.1% Tween PBS (PBST). Membranes were then washed three times in PBST at RT,
incubated with appropriate secondary antibodies: donkey αgoat-HRP and horse αmouse-HRP,
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both (Jackson Labs 1:10,000) and washed three times in PBST at RT. Membranes were then
incubated in ECL solution and imaged using the digital ChemiDoc imaging system (Promega).
In situ hybridisation
Shh and Ptch1 vectors and probes were previously described [11]. Primers incorporating
restriction enzymes sites were used to amplify the probe from full-length cDNA template tem-
ples. Products were cloned into Bluescript SK and KS for antisense and control sense probe
production. Riboprobes were generated from linearised vector templates using the MEGA-
script kit (Life technologies) as per the manufacturer’s instruction. Embryos were dissected and
fixed in 4% paraformaldehyde (Sigma) overnight at 4°C. In situ hybridisation was carried out
as previously described [11]. Expression patterns were detected by the alkaline phosphatase
substrates nitro-blue tetrazolium chloride (NBT) and 5-bromo- 4-chloro-3'-indolyphosphate
p-toluidine (BCIP) (Roche).
General animal work
Animal studies were approved by Medical Research Council Institute of Genetics and Molecu-
lar Medicine ‘Animal Care and Use Committee’ (applications PL21–06 and PL26–11) and car-
ried out according to guidance issued by the Medical Research Council in Responsibility in the
Use of Animals for Medical Research (July 1993), EU Directive 2010 and UK Home Office
Project License no PPL 60/4424. Mice had constant access to food and water and were main-
tained on 12 hour light and dark cycles. Pups were weaned at three weeks old at which point
ear clips were collected for genotype analysis. Timed matings were set up with E0.5 (embryonic
day) taken as the morning a vaginal plug was detected. Following Schedule 1 sacrifice of the
mother (CO2 asphyxiation followed by cervical dislocation), embryos were dissected out using
a Leica EZ4HD dissecting microscope. Genomic DNA was extracted either from adult mouse
earclips or embryo yolk sacs and analysed using the HotShot DNA extraction technique [33]
using Platinum Taq (Invitrogen) according to the manufacturer’s instruction. Primers used
were: Wild type Ubr5 For 5’ GTT TCT GGC AAG GTT CAG TGC; Rev 5’ CAC ACA TGC
TGC ACA AAC ACA TG; Ubr5mt For 5’ GTT TCT GGC AAG GTT CAG TGC; Ubr5mt
Rev 5’ GCC ACT ATG CGC ACA GCT GG; Ubr5WT For 5’ CGC GAA GAG TTT GTC
CTC AC; Ubr5WT Rev 5’ GCC TCG ATC CTC CCT TTA TC; Neomycin For 5’ TGT TCC
GGC TGT CAG CGC AG; Neomycin Rev 5’ GAT ATT CGG CAA GCA GGC ATC; FLP For
5’ AGG GTG AAA GCA TCT GGG AGA; FLP Rev 5’ TCA ACT CCG TTA GGC CCT TCA;
Cre For 5’ GCA TTA CCG GTC GAT GCA ACG AGT GAT GAG; Cre Rev 5’ GAG TGA
ACG AAC CTG GTC GAA A.
Creation of the conditional Ubr5mtmouse
E14 embryonic stem (ES) cells carrying the Ubr5 gene trap EUCE0171f01 were obtained from
EUCOMM (European Conditional Mouse Mutagenesis Program). Chimeric mice were gener-
ated by injection of E14 mouse ES cells positive for the gene trap into C57BL/6J ES blastocysts
that were transferred to pseudopregnant C57BL/6J females. Germline offspring were identified
by coat colour and PCR genotyping confirmed the presence of the modified allele. Mice were
then crossed to, and subsequently maintained on, a C57BL/6J background.
Conditional disruption of Ubr5 expression
For conditional studies, mice were first crossed to a mouse line expressing an enhanced form of
Flippase (Flp-e) [34]. The presence of the inverted genetrap (Ubr5WT

) was confirmed by PCR.
Characterisation of a Conditional Ubr5mt Allele
PLOS ONE | DOI:10.1371/journal.pone.0157079 June 14, 2016 4 / 28
Ubr5 expression was conditionally ablated in the whole embryo or limb buds by crossing Ubr5WT

with pCAGG-Cre-ERT2[35] or Prx1-Cre [36] mice, respectively. Animal stocks were maintained as
heterozygotes. Crosses were carried out using heterozygous animals to permit littermate controls
and Cre was passed through the male germline. For viability studies, pregnant females underwent
intraperitoneal (i.p.) injections of 4mg Tamoxifen (Sigma, stock 20mg/ml) at 11.5 days post coi-
tum (dpc), followed by embryo collection at E13.5, E15.5 or E17.5.
X-gal staining
X-gal staining was carried out as previously described [11]. Briefly, embryos were dissected
out, fixed in 4% PFA at 4°C, washed and stained overnight. Stained embryos were then imaged
whole mount and then sectioned for histology.
Embryo embedding, sectioning and histological processing
Embryos were hand embedded in paraffin wax as per established in-house protocols. Wax
blocks were allowed to solidify for three hours on a cold block, then mounted on wooden
blocks and 4–8μm sections cut using a microtome (Leica). Sections were floated on a 45°C
water bath prior to mounting on SuperFrost1 slides (Fisher) which were left to dry overnight
at 37°C prior to staining. Sections were de-waxed and stained using standard histological tech-
niques for haematoxylin, alcian blue and alizarin (Sigma) staining.
Macroscopy
Colour brightfield imaging of all embryos and embryo limbs was carried out on a Nikon
AZ100 macroscope attached to a QImaging Micropublisher. Images were captured using
IPLab software (Scanalytics). Histological sections were scanned using a Nanozoomer slide
scanner (Hamamatsu) and visualised using NDPview2 software (Hamamatsu).
Optical Projection Tomography (OPT)
OPT was carried out as previously described [37]. Briefly, embryos were fixed overnight using
4% paraformaldehyde, transferred to PBS and embedded in 1% low melting point molten aga-
rose, dehydrated overnight and then cleared in a 2:1 mixture of benzyl alcohol to benzyl benzo-
ate. Sample autofluorescence was analysed using a Bioptonics 3001 OPT scanner and
reconstructed using Bioptonics view software.
Statistics and computer programmes
Microsoft Excel and GraphPad Prism were used for graphs and the indicated ANOVA and t-test
statistical analysis. Graphs indicate p values with the following key:  =0.0001;  =0.001;
 =0.01;  =0.05 and ns =0.05. Adobe Photoshop CS6 and Illustrator CS6 were used to
produce the figures.
Results
Retinoic acid promotes Shh expression in murine ES cells
Based upon the ability of Hyd, the Drosophila orthologue of UBR5, to influence hh ligand
expression we wished to examine whether murine UBR5 was capable of regulating Shh expres-
sion. We chose to use an E14 mouse embryonic stem (mES) cell system that utilises retinoic
acid (RA) treatment to induce Shh expression[38]. In contrast to Okada et al, we utilised condi-
tions to restrain embryoid body formation and ES cell differentiation (i.e., retention of LIF[39]
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and 10% FBS[40] in the ES cell media throughout). Initially we confirmed that RA stimulation
promoted mES cells to express Shh (Fig 1A). 24 hrs post-RA-treatment, Shh levels were readily
detectable by RT-PCR, with doses as low as 0.1μMRA inducing significant Shh expression
[41]. More detailed analysis of the inductive response with 0.1μM RA revealed peak Shh
expression 48–72hrs after treatment (Fig 1B). At 96 hrs post-treatment, an increase in Shh
expression was also detected in vehicle (DMSO) treated cells, potentially reflecting a possible
effect of increased cell confluence.
Analysis of UBR5 protein expression in RA-treated cells revealed a significant reduction at
48hrs post-treatment (Fig 1C), which was sustained up to the end of the time course at 96hrs.
To address if the loss of UBR5 expression 96hrs post-RA-treatment was due to transcriptional
changes we used qRT-PCR analysis, which revealed no significant reduction (Fig 1D). These
results suggested that the reduction in UBR5 expression was potentially via a post-transcrip-
tional mechanism. Intriguingly, maximal Shh expression (48–72hrs post-RA-treatment) coin-
cided with the marked reduction in UBR5 expression. However, at 24hrs post-RA-treatment,
at a time Shh was initially induced (Fig 1B), UBR5 expression was not reduced (Fig 1C). In
summary, it appeared that reduced UBR5 protein levels did not coincide with the initial induc-
tion of Shh, but did coincide with the subsequent increase in Shh expression level.
UBR5 promotes RA-mediated Shh expression
Due to the reciprocal association of UBR5 and Shh expression levels, we reasoned that, similar
to Hyd’s ability to suppress hh expression [15, 16], UBR5 also functioned as a negative regula-
tor of RA-mediated Shh expression. To address this we created stable pools of mES cells lines
expressing three different Ubr5 shRNAis or a control scrambled (SCR) shRNAi. Western blot
analysis revealed normal levels of UBR5 expression in the SCR pool, but moderate (Ubr5.1),
intermediate (Ubr5.3) and strong (Ubr5.2) reductions in UBR5 expression in Ubr5 shRNAi
pools (Fig 2A). We next challenged the SCR and Ubr5 shRNAi pools (Ubr5.1 and Ubr5.2) with
RA and assessed their ability to express Shh by qRT-PCR (Fig 2B). In comparison to the SCR
control line, both Ubr5 shRNAi pools exhibited dramatically impaired Shh expression
responses to RA stimulation. Interestingly, the initial Shh induction at 24 hrs was either unaf-
fected (Ubr 5.2) or enhanced (Ubr5.1) over SCR control levels. However, both Ubr5 shRNAi
pools failed to significantly increase Shh expression over time. In comparison to the maximal
Shh expression achieved in the SCR pool at 72hrs post RA-treatment, Ubr5 shRNAi pools
exhibited an approximately three-to-five-fold decrease. We therefore concluded that in our ES
cell system UBR5 promoted RA-mediated Shh expression. This finding was in contrast to the
identification of Hyd as a suppressor of hh expression [15], but did support a potential role for
UBR5 in regulation of hh ligand expression.
The inability ofUbr5 shRNAi cells to maintain Shh expression could have been explained by
(i) an inability of ES cells to produce Shh or (ii) differentiation of ES cells into a non-Shh-express-
ing cell types. To address the latter, we assessed expression of a number of ES-cell associated
markers (Nanog)[42], Klf-4[43] and Bmp-4[42, 44]. sqRT-PCR analysis revealed no dramatic dif-
ferences in expression levels between SCR andUbr5shRNAi pools (Fig 2C). Therefore, based on
expression analysis of a limited set of markers,Ubr5 shRNAi did not appear to affect ES pluripo-
tentcy. While we cannot rule out a contribution of altered ES differentiation, we believe UBR5
cells plays a more direct role in influencing RA-mediated Shh expression within ES cells.
Ubr5mt/mt embryos phenocopy the Ubr5 null phenotype
Due to its well-described roles in limb patterning and development[1], we chose to examine
the effects of loss of Ubr5 function in limb bud mesenchyme. As Ubr5 null embryos are
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embryonic lethal [45] we developed a conditional mutant allele. We utilised a EUCOMMUbr5
conditional gene trap (Ubr5gt) inserted between exons 20–21 (Fig 3A) to interfere with Ubr5
mRNA expression and UBR5 protein function. The gene trap was capable of existing in three
distinct states [46] depending on the sequential action of FLP- and CRE-recombinases (Fig
3B): (1) in the absence of recombinase the gene trap resided in the mutagenic orientation
(Ubr5mt); (2) after FLP-mediated recombination, in the non-mutagenic orientation (Ubr5WT

);
and (3) after CRE-mediated recombination, in the mutagenic orientation (Ubr5mt

). When in
the mutagenic orientation the predicted fusion protein consists of UBR5’s N-terminal UBA
domain fused with a β-galactasidase:aminoglycoside 3' phosphotransferase fusion protein
(βGEO); with the βGEO protein conferring both X-gal staining and Neomycin resistance. Such
a fusion of UBR5’s UBA domain with βGEO, herein referred to as UBR5MT, was predicted to
be severely functionally impaired due to lack of its important domain-associated functions: (i)
E3 activity due to loss of the C-terminal catalytic HECT domain [20], (ii) N-end rule function
through loss of the UBR domain [17] and (iii) miRNA regulatory function due to the absence
of its Poly(A)-binding protein C-terminal (PABC) domain [47].
To confirm that the UBR5MT fusion protein was functionally impaired, we compared FLP-
treated (Ubr5WT
/WT) controls (Fig 3C), heterozygous (Ubr5mt/+) (Fig 3D) and homozygous
(Ubr5mt/mt) Ubr5mt (Fig 3E) E9.5 embryos. Ubr5mt/mt embryos, in comparison to control or
heterozygous embryos, appeared developmentally abnormal (Fig 3E), with an estimate of the
apparent development stage being around E8.5. As expected these animals also exhibited a dra-
matic decrease in Ubr5 expression (Fig 3F). Furthermore, qRT-PCR analysis of whole embryo
extracts revealed a small, but significant, decrease in Shh expression in E9.5 Ubr5mt/mt embryos
(Fig 3G). This observation alone provided some support to the idea that UBR5 influenced Shh
expression in vivo, even though the effects were small. However, we reasoned that the reduc-
tion in Shh expression might have simply reflected the developmental retardation of Ubr5mt/mt
embryos. In agreement, Ubr5mt/mt Shh expression levels more closely resembled that of control
E8.5 embryos (Fig 3G). These observations suggested that Ubr5mt/mt embryos exhibited molec-
ular signatures (i.e., reduced Shh expression) that potentially reflected their state of embryonic
retardation.
To ensure that the Ubr5mt allele functionally phenocopied the embryonic lethality of the
null allele [45], we analysed the progeny of a heterozygous cross (Ubr5mt/+). The resultant lit-
ters revealed a total absence of Ubr5mt/mt animals (Table 1). Hence, we were reassured that the
Ubr5 gene-trap functionally phenocopied the Ubr5 null.
Ubr5mt/mt embryos do not resemble Shh null embryos
We next used optical projection tomography (OPT) to compare control (CD1) and Ubr5mt/mt
E9.5 embryos in more detail (Fig 4). Specifically we wished to address whether the Ubr5mt/mt
embryos bore any resemblance to Shh defective embryos. Embryos deficient in Shh die during
late embryonic development and display disruption of midline structures, cyclopia and limb
deformities>E10.5 [48, 49]. Unfortunately, the death and reabsorption of Ubr5mt/mt embryos
by E11.5 precluded detection of any Shh-associated mid-gestation phenotypes. However,
Fig 1. Retinoic Acid induces Shh and suppresses UBR5 expression.Murine E14 ES cells were treated
with (A) the indicated concentration of RA, or (B-D) 0.1μMRA or DMSO (Vehicle) and analysed by RT-PCR
at (A) 24hrs and (B) at the indicated times post-RA-treatment. (C) SDS-PAGE andWestern blotting
determined UBR5 expression over the indicated RA time course. An asterisk denotes an uncharacterised,
faster migrating UBR5 antibody reactive species. Tubulin was used as a loading control. (D) qRT-PCR of
Ubr5 expression normalised against β-actin in mES cells 96hrs post-RA-treatment (n = 3, s.e.m indicated).
Statistical analysis by Students t-test. ns = not significant.
doi:10.1371/journal.pone.0157079.g001
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additional Shh null defects that present earlier than E10.5 were not apparent in E9.5 Ubr5mt/mt
embryos: namely defects in the neural tube / floor plate (Fig 4 compare A and C, arrows) or
closure of the dorsal and ventral surfaces around the dicephalic-mesencephalic junction (Fig 4
compare B and D, asterisk). Nevertheless, OPT did confirm that the morphology of these struc-
tures were clearly different to that of the age matched control embryos.
Further comparisons revealed that the E9.5 Ubr5mt/mt animals exhibited (i) kyphotic, rather
than lordotic, curvature of the spine (Fig 4, compare E,I), (ii) an open, rather than closed, pos-
terior neuropore (Fig 4, compare F,J dashed lines), (iii) one, rather than two, clearly defined
pharyngeal arches (Fig 4, compare E,H with K,L, arrows) and (iv) ~12, rather than 24, somite
pairs (Fig 4, compare G,H with J, arrowheads). Furthermore, there was some evidence of
somite misalignment (Fig 4J), a defect associated with loss of Shh function [49].
Taken together these results supported the idea that Ubr5mt/mt embryos were clearly devel-
opmentally abnormal. However the E9.5 Ubr5mt/mt embryos did not resemble Shh null animals,
but did phenocopy the previously reported Ubr5 null morphological phenotype [45].
UBR5 function is required for mid-gestation embryonic viability
To address the role of Ubr5 at later stages and to examine any Hh-associated defects occurring
during midgestation (>E10.5) we coupled the conditional Ubr5WT

allele with the tamoxifen
inducible Cre-ERT2 system [50] driven by expression from the artificial CAGG promoter [51].
Pregnant females bearing Cre-ERT2;Ubr5WT
/WT progeny were injected daily with tamoxifen
at E10.5 over four days. Genotyping the embryos at E15.5 revealed a total absence of the Cre-
ERT2; Ubr5mt
/mt genotype and a reduction in the observed/expected frequency of Cre-ERT2;
Ubr5mt
/+ embryos (Table 2). In a further attempt to recover Ubr5mt
/mt embryos for morpho-
logical analysis, we repeated the experiment and harvested the embryos at E13.5. Again, E13.5
analysis revealed the same absence of the Cre-ERT2; Ubr5mt
/mt embryos (Table 3), as well as a
detrimental effect on heterozygous embryo viability (Tables 2 and 3). These results suggested
that during midgestation Ubr5 gene dosage was important for its embryonic function. Impor-
tantly, tamoxifen-mediated Cre activity alone (Cre-ERT2) had no detrimental effects on embry-
onic viability. Taken together this data suggested that the Ubr5WT

allele was amenable to Cre-
mediated conversion into the Ubr5mt

allele and that UBR5 function was required for mid-ges-
tation embryonic viability.
Ubr5/UBR5 is expressed in the limb buds
Once the Ubr5gt construct had been functionally validated, we chose to utilise the gene trap’s
lacZ reporter gene to establish UBR5 protein expression, with a particular focus on the limbs.
E9.5, E10.5 and E11.5 embryos heterozygous for Ubr5mt underwent X-Gal staining (Fig 5A–
5F). No significant staining was detected in control Ubr5+/+ embryos (Fig 5A, 5C and 5E). In
contrast, Ubr5mt/+ embryos at E9.5, E10.5 and E11.5 (Fig 5B, 5D and 5F, respectively) exhibited
widespread low-level X-Gal staining in addition to well-defined stronger signals. At all stages
Ubr5mt/+ embryos revealed distinct signals associated with the dorsal edge (Fig 5B, 5D and 5F
Fig 2. UBR5 is required for RA-mediated induction of Shh. Pools of murine E14 mES cells expressing
either scrambled control (SCR) or Ubr5 shRNAi were tested for (A) UBR5 expression by SDS-PAGE and
Western blotting, using Tubulin as a loading control; (B) RA-mediated Shh induction by qRT-PCR (n = 3,
relative expression levels to β-actin, s.e.m indicated) or (C) expression analysis of the indicated ES cell
pluripotentcy markers in shRNAi pools or parental ES cells by sqRT-PCR. For (B) comparison of all matched
time points post-RA-treatment between control andUbr5 shRNAi pools revealed statistically significant
differences (p = <0.01), apart from the comparison between control andUbr5.2 at 24 hours, which was not
significant (ns). Statistical analysis by one-way ANOVA and Tukey multiple comparison test.
doi:10.1371/journal.pone.0157079.g002
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arrows) in addition to signals in the pharyngeal arches and forebrain (Fig 5B, 5D and 5F
dashed lines labelled PA and FB, respectively). At E9.5, a signal within the body core potentially
indicated expression within the foregut (Fig 5B, labelled FG). At E10.5, the staining along the
dorso-lateral edge shifted posteriorly towards the tail (Fig 5D, posterior arrow) and by E11.5,
the striated β-Gal activity was still present along the dorsal edge, but had become more medial
(Fig 5F, arrows). Additionally, X-Gal staining became more prominent in the forebrain (Fig 5
dashed lines, FB) and body core (Fig 5F asterisk). Staining in both fore- and hind-limbs was
detected at E10.5–11.5, with the fore-limbs exhibiting more robust staining (Fig 5D–5F dashed
lines, FL and HL). In summary, the β-Gal activity exhibited dynamic expression patterns in a
number of structures that included, at certain stages, both fore- and hind-limbs.
We next wished to compare UBR5-associated β-Gal activity with Shh expression patterns.
Shh in situ hybridisation at E9.5, E10.5 and E11.5 (Fig 5G–5I) revealed the expected expression
in the fore- and hind-gut (labelled FG and HG, respectively), brain (labelled BR), floorplate of
the neural tube (labelled FP) and the ZPAs of the fore- and hind-limbs (labelled FL-ZPA and
HL-ZPA, respectively). By E11.5 Shh expression was predominantly restricted to the limb buds
and the zones of polarising activity (Fig 5H and 5I labelled ZPA). In contrast to the poster-
ioirised Shh expression in the forelimb, UBR5-associated β-Gal activity appeared to be pre-
dominantly in the anterior regions of the E10.5 and E11.5 forelimb buds (Fig 5K–5M,
respectively). However, in the E10.5 hindlimb β-Gal activity was evenly expressed across the
entire limb bud (Fig 5L). In general, the overall expression patterns of Shh and UBR5-asso-
ciated β-Gal activity revealed no strong evidence for either a clear mutually-exclusive or -inclu-
sive expression pattern. However, Ubr5 expression within the limb buds did provide a
possibility for UBR5 to tissue autonomously regulate Hh signalling within the embryonic limb.
The β-Gal assays suggested that Ubr5/UBR5mt was expressed in E10.5 and E11.5 limb buds.
To confirm that endogenous UBR5 protein was also expressed, we used SDS-PAGE and West-
ern blotting of E11.5 limb lysates (Fig 5O). Samples were separated into crude nuclear and
cytoplasmic fractions and blotted for UBR5 and cytoplasmic (tubulin) and nuclear (HP-1)
markers. Analysis revealed that UBR5 was expressed in both the fore- and hind-limbs and was
present in both the cytoplasmic and nuclear fractions. Due to potential cytoplasmic contamina-
tion, as indicated by the presence of β-tubulin in the nuclear fraction, we were unable to
Fig 3. TheUbr5 gene trap phenocopies theUbr5 null phenotype. (A) Schematic representation of the EUCOMMEUCE0171f01
gene trap introduced in between exons 20 and 21 of the murineUbr5 gene. FRT, loxP and lox511 recombination sites, and their
orientation, are indicated as triangles and flank the gene trap encoding for a splice acceptor site (SA), a LacZ and neomycin CDS
(βgeo) and a poly-adenylation signal (pA). (B) Schematic representation of the effects of FLP and Cre-mediated recombination on
the gene trap and UBR5 protein/domain expression–see text for details. (C-E) Brightfield images of control (C) Ubr5WT*/WT*, (D)
Ubr5mt/+ and (E) Ubr5mt/mt E9.5 embryos. Scale bar = 1mm.Whole embryo qRT-PCR analysis of (F) Ubr5 at E9.5 and (G) Shh
expression in the indicated genotypes at E9.5 or E8.5. Con = Ubr5+/+. n = 6, s.e.m indicated. Statistical analysis by Students t-test.
ns = not significant.
doi:10.1371/journal.pone.0157079.g003
Table 1. E11.5Ubr5mt/mt embryos are not viable.
Genotype Expected Frequency (%) Observed Frequency (%)
Ubr5+/+ 25% 26% (n = 7)
Ubr5mt/+ 50% 74% (n = 20)
Ubr5mt/mt 25% 0% (n = 0)
Embryos from a Ubr5mt/+ cross were genotyped and their representation expressed as a percentage of the
total litter size. n = 27. Chi squared test p = 0.0071.
doi:10.1371/journal.pone.0157079.t001
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conclude that UBR5 is nuclear localised in limb bud cells. Nevertheless, techniques to identify
UBR5:βGeo-associated β-Gal activity (Fig 5B, 5D, 5F and 5K–5M) and endogenous protein
expression (Fig 5O) revealed that Ubr5/UBR5 was expressed in E11.5 embryonic limb buds.
Fig 4. E9.5Ubr5mt/mt embryos are developmentally abnormal.Optical projection tomography images of Ubr5+/+ (Con) (A,B, E-H) andUbr5mt/mt (C,D, I-L)
E9.5 embryos. BothUbr5mt/mt and Con embryos formed a neural floorplate (A,C arrows) and separated the plates of the diencephalic-mesencephalic
junction (B,D asterisks). In comparison to control embryos, E9.5Ubr5mt/mt embryos exhibited numerous developmental defects: an open posterior neuropore
(J dashed line), irregular somites that were also reduced in number (compare G,H with J, arrowheads); lordotic curvature (L) and only one pair of pharyngeal
arches (compare E,H with K,L arrows). n = 1. Scale bar (A-C) = 200μm and (E-L) = 1mm.
doi:10.1371/journal.pone.0157079.g004
Table 2. Ubr5 is required for embryonic mid-gestational viability—E15.5 analysis.
Genotype Expected Frequency (%) Observed Frequency (%)
Ubr5+/+ 12.5 14 (n = 5)
Ubr5+/+; CreERT2 12.5 25 (n = 9)
Ubr5WT*/+ 25 36 (n = 13)
Ubr5mt*/+; CreERT2 25 11 (n = 4)
Ubr5WT*/WT* 12.5 11 (n = 4)
Ubr5mt*/mt*; CreERT2 12.5 0 (n = 0)
doi:10.1371/journal.pone.0157079.t002
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Prx-Cre1-mediated recombination of the Ubr5WT* allele effectively
suppressesUbr5 expression in developing limbs
The combination of (i) our observation of UBR5’s effects on RA-mediated Shh expression, (ii)
the importance of RA and SHH-mediated signalling in limb development and (iii) Ubr5/UBR5
expression within the limb prompted us to delete UBR5 expression in the developing limb.
Accordingly, we chose to combine the Ubr5WT

allele with Prx1-mediated expression of Cre
recombinase (Prx1-Cre). Expressed throughout the E9 limb bud mesenchyme, Prx-1-Cre medi-
ates recombination in all mesenchymal cells by mid-bud development at E11 [36]. To confirm
the efficiency of Prx1-Cre-mediated recombination, control and experimental E13.5 embryos
were assayed for β-gal activity (Fig 6A–6C). Note that F1 progeny bearing both Prx1-Cre and
Ubr5WT
/WT were assumed to have undergone temporally- and spatially-restricted recombina-
tion and from herein will be indicated as Prx1-Cre;Ubr5mt
/mt.
Prx-Cre;Ubr5mt
/mt embryos exhibited robust β-gal activity within the limbs (Fig 6C) that
was absent in Ubr5+/+ and Ubr5WT
/WT controls (Fig 6A and 6B, respectively). In Prx-Cre;
Ubr5mt
/mt embryos, significant signals were also detected outside of the limbs and included
regions above the eye (Fig 6C white arrow), around the ear (Fig 6C black arrow), the snout (Fig
6C black arrowhead) and head (Fig 6C, white arrowhead). These observations indicated that
both Prx1-Cre and Ubr5 were expressed within, as we well as outside of, the limb fields. In sum-
mary, these results confirmed (i) efficient Cre-mediated gene conversion and (ii) Ubr5/UBR5
expression within the fore- and hind-limbs.
Haematoxylin-based histological examination of the Prx-Cre;Ubr5mt
/mt footplate revealed
a dark staining epidermal layer (Fig 6D, arrowhead), chondrocyte condensations within the
developing digits and surrounding dark staining mesenchymal cells (Fig 6D, red and white
dashed lines respectively). Proximally extending structures indicative of developing sinews
radiated out from the mid-region of the footplate (Fig 6D, red dotted lines). Examination of an
adjacent unstained section revealed widespread β-Gal activity (UBR5MT) across the footplate
(Fig 6E). Regions of high expression appeared to reside around and between the chondrocyte
condensations as well as within the developing sinews. In contrast, β-Gal activity appeared to
be either low or absent within the chondrocyte condensations and epidermis (Fig 6, red dashed
line and arrowhead, respectively). In summary, within the Prx1-Cre;Ubr5mt
/mt forelimb,
UBR5MT exhibited a non-uniform expression pattern and appeared to be excluded from con-
densing chondrocytes.
We next carried out qRT-PCR analysis on Prx-Cre;Ubr5mt
/mt limbs to quantify the extent
of gene conversion through increased LacZ expression (Fig 6F) and confirm that Ubr5
Table 3. Ubr5 is required for embryonic mid-gestational viability—E13.5 analysis.
Genotype Expected Frequency (%) Observed Frequency (%)
Ubr5+/+ 12.5 20 (n = 7)
Ubr5+/+; CreERT2 12.5 29 (n = 10)
Ubr5+/WT* 25 20 (n = 7)
Ubr5+/mt*; CreERT2 25 3 (n = 1)
Ubr5WT*/WT* 12.5 29 (n = 10)
Ubr5mt*/mt*; CreERT2 12.5 0 (n = 0)
Ubr5 function is required for mid-gestation viability. Pregnant females were injected i.p with tamoxifen at
E11.5 and embryos genotyped at E13.5 (Table 3) and E15.5 (Table 2). Chi squared analysis: E15.5 = p
0.0179 and E13.5 = p = 0.0001.
doi:10.1371/journal.pone.0157079.t003
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expression was also reduced (Fig 6G). LacZ primers targeting expression of Ubr5mt

mRNA
revealed no signal in Prx1-Cre animals, but detected low-levels in heterozygous and homozy-
gous Ubr5WT

-bearing animals that lacked Prx1-Cre. Nevertheless, the presence of Prx1-Cre
promoted a 15–40 fold increase in LacZ expression in either heterozygous or homozygous
Ubr5mt backgrounds (Fig 6F). Interestingly Prx1-Cre;Ubr5mt
/mt exhibited only ~33% more
LacZ expression than Prx1-Cre;Ubr5mt
/+, suggesting either non-linear gene dosage effects and/
or limiting recombinase activity.
To quantifyUbr5 expression, we used primer pairs complementary to the 3’ end ofUbr5




, alleles. In agreement with the
increased β-Gal staining (Fig 6C) and LacZ expression analysis (Fig 6F), full-lengthUbr5 expres-
sion levels were significantly reduced in Prx1-Cre limbs either heterozygous or homozygous for
Ubr5mt

(Fig 6G); with the greatest reduction occurring in the homozygousUbr5mt
/mt limbs. Sur-
prisingly, homozygosity for the non-mutagenicUbr5WT

allele, in the absence of Prx1-Cre, caused
a small but significant decrease inUbr5 expression. This observation indicated that physical inser-
tion of the gene-trap (Fig 6F) had a detrimental effect onUbr5mRNA expression.
Fig 5. Expression analysis of UBR5MT, Shh and endogenous UBR5. β-Gal activity was not detected in wild-type controls (Con) embryos (A,C,E),
whereas Ubr5mt/+ embryos exhibited staining at (B) E9.5, (D) E10.5 and E11.5 (F). Dashed lines indicate areas of interest. Please see text for more details.
(G-I) Shh in situ hybridisation of wild-type control embryos at the indicated embryonic stages. FB = forebrain; HB = hindbrain; PA = pharyngeal arches;
FG = foregut; HG = hindgut; FL = forelimb; HL = hindlimb; BR = brain; FP = floorplate; ZPA = zone of polarising activity; an asterisk marks a potential
gastrointestinal signal. Scale bars = 1mm. (J-M) Higher magnification images of E10.5 (J-L) and E11.5 (M) limbs of the indicated genotypes. A dashed line
outlines the limb bud margins. Representative images shown from n =3 for each stage and genotype. (O) SDS-PAGE andWestern blotting of E11.5 fore-
and hind-limb lysates for UBR5 expression in cytosolic (Cyto) and nuclear (Nuc) fractions. HP1 (a nuclear marker) and β-tubulin (a predominantly cytosolic
marker) were used as loading and fractionation controls. n = 1.
doi:10.1371/journal.pone.0157079.g005
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Ubr5mt E13.5 limbs exhibit decreased Hedgehog pathway activity
Having established that Ubr5 was expressed in the limb and that the Ubr5gt was functional, we
wanted to address whether loss of Ubr5 expression in the developing limb would affect Hedge-
hog signalling (Fig 7). qRT-PCR analysis of the Hh pathway target gene Ptch1 revealed that at
E13.5 HhP activity was repressed in both the fore- and hind-limb (Fig 7A). At E15.5, the levels
of Ptch1 expression appeared to be either overcorrected (forelimb) or corrected (hindlimb) rel-
ative to control levels (Fig 7B). Similar to Ptch1 expression, Gli1 expression was also repressed
in both limbs, although only the reduction in the forelimb was statistically significant (Fig 7C)
and was then corrected, to some degree, by E15.5 (Fig 7D).
In summary, at E13.5 it appeared that loss of Ubr5 in the forelimb resulted in a decrease in
the HhP’s transcriptional outputs. Within the hindlimb, however, the reduction in HhP tran-
scriptional output was less pronounced, Some of the differences between fore- and hind-limbs
may have reflected the difference in developmental timing between the two structures, with the
forelimb initiating development prior to the hindlimb (EMouse Atlas Project). Overall, these
results suggested that loss of Ubr5 function resulted in a transient repression of Hh signalling.
Significant quantitative changes in Ptch1 gene expression at E13.5 led us to investigate its
spatial expression pattern at E11.5. Using ISH, we examined Ptch1 expression in both fore- and
hind-limb buds of E11.5 embryonic fore- and hind-limbs of control Prx1-Cre (Fig 8A) and
experimental Prx1-Cre; Ubr5mt/mt (Fig 8B) embryos. Comparison between the two genotypes
revealed no dramatic differences in spatial expression patterns, although Ubr5mt/mt hindlimbs
exhibited a small reduction in Ptch1 signal intensity (Fig 8B). Analysis of Shh expression
showed no differences in its spatial expression patterns (Fig 8C and 8D). Taken together these
data revealed that Prx1-Cre-mediated loss of UBR5 function did not dramatically affect Shh or
Ptch1 spatial expression patterns in E11.5 embryonic limbs. In combination with the qRT-PCR
analysis, we concluded that in Ubr5mt limbs the effect on Hedgehog signalling were transient
and predominantly affected the magnitude of mRNA expression around E11.5-E13.5.
Ubr5-deficient embryonic limbs do not exhibit digit abnormalities
Although the E11.5 limb buds showed no obvious changes in the spatial expression of Shh, the
E13.5 limbs did exhibit a reduction in HhP activity. We hypothesised that even a transient
reduction might manifest a subsequent morphological/developmental defect. Accordingly, we
examined the digits of E15.5 control Prx1-Cre and Prx1-Cre, Ubr5mt
/mt fore- and hind-paws,
which revealed no gross abnormalities (Fig 9A–9D). Although measurement of Ubr5mt
/mt
forelimb digits revealed a reduction in average length (Fig 9E), the effects proved not to be sta-
tistically significant.
Fig 6. Prx-Cre1-mediated recombination of theUbr5gt and loss of Ubr5 expression. Prx1-Cre promotes UBR5MT-
associated β-Gal activity (A-E), lacZ expression (F) and (G) loss of Ubr5 expression. (A-C) E13.5 embryos of the indicated
genotypes stained for β-Gal activity revealed strong X-Gal staining in the embryonic limbs, in addition to other regions:
above the eye, white arrow; the ear, black arrow; snout black arrowhead and head, white arrowhead. Scale bar = 1mm.
(D-E) Histological sections through the footplate revealed a non-uniform UBR5MT expression pattern (red dashed
lines = chondrocyte condensations; white dashed lines = dark staining mesenchyme and red dotted line = developing
sinews). Scale bar = 250μm. qRT-PCR analysis of (F) LacZ expression and (G) full-lengthUbr5 in dissected E13.5 fore-
and hind-limb buds. Prx1-Cre in combination with heterozygosity or homozygosity for the Ubr5mt* allele exhibited (F) a
dramatic increase in LacZ expression and (G) a dramatic decrease inUbr5 expression in comparison to Prx1-Cre only
(Con). The primer pairs in (G) were specific for a gene region absent in theUbr5mt* transcript. All differences relative to the
appropriate Prx1-Cre controls (Con) were statistically significant (at least p = <0.05), apart from the comparison between
Con andUbr5mt*/mt*, which was not significant (ns). n =3, s.e.m indicated. Statistical analysis by one-way ANOVA and
Tukey multiple comparison test.
doi:10.1371/journal.pone.0157079.g006
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Histological analysis of Prx1-Cre;Ubr5mt
/mt mutant feet and paws using haematoxylin or
alizarin red/alcian blue revealed no obvious defects in digit formation, or composition (Fig 9F–
9I). Closer analysis of Prx1-Cre and Prx1-Cre;Ubr5mt
/mt developing tarsals (Fig 9J–9M) also
revealed no dramatic effects on chondrocyte condensations (Fig 9 compare J,L) or upon the
associated deposition of Alcian-blue-reactive acidic polysaccharides (cartilage) (Fig 7 compare
Fig 7. Loss ofUbr5 function resulted in decreased expression of Ptch1 andGli1 at E13.5. (A-D) qRT-PCR analysis of Prx1-Cre (Con) and Prx1-Cre;
Ubr5mt*/mt* (Ubr5mt*/mt*) E13.5 or E15.5 embryonic fore- and hind-limbs for Ptch1 (A,B) andGli1 (C,D) expression. qRT-PCR of target genes were
normalised against β-actin (n =3, s.e.m indicated). Statistical analysis by Students t-test. ns = not significant.
doi:10.1371/journal.pone.0157079.g007
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K,M). Therefore, it appeared that there were no obvious morphological/histological defects in
Ubr5mt
/mt digits.
Ubr5-deficient embryonic limbs exhibit reduced Ihh expression
The lack of any digit phenotype suggested that the observed changes in HhP activity had no
impact on digit development. In simplistic terms, Shh-mediated signalling controls limb/digit
formation; whereas, Ihh regulates the subsequent growth, maturation and homeostasis of the
limbs’ long bones [52, 53]. We therefore hypothesised that reduced Ihh expression could
account for the decrease in HhP activity and might elicit an effect on embryonic long bone
length. qRT-PCR analysis revealed a significant reduction in Ihh expression in E13.5 Prx1-Cre;
Ubr5mt
/mt limbs (Fig 10A), with only the reduction in the hind limbs persisting through to
E15.5 (Fig 10B).
At E13.5-E15.5 Shh expression in the limb bud is dramatically reduced[54–56] and Shh
analysis revealed no significant difference between control and Prx1-Cre;Ubr5mt
/mt fore limbs
at either time point (Fig 10C and 10D). However, at both developmental stages, Prx1-Cre;
Ubr5mt
/mt hindlimbs exhibited small, but significant decreases (Fig 10C and 10D). It should
be noted that the Shh detected at>E13.5 was most likely in non-mesenchymal-derived devel-
oping hair follicles[57] and therefore not directly affected by Prx1-Cre-mediated loss of Ubr5
Fig 8. Loss ofUbr5 at E11.5 does not affect Shh or Ptch1 expression domains. In situ hybridisation for
expression of Hh signalling components Ptch1 (A,B) and Shh (C,D) in E11.5 embryos of Prx1-Cre (Con) and
Prx1-Cre;Ubr5mt*/mt* (Ubr5mt*/mt*) embryos. Analysis revealed no significant effects on either Shh or Ptch1
expression patterns in the Ubr5mt*/mt* embryos (representative image from n = >4 of each genotype).
Arrowheads indicate Shh ZPA expression domains. Scale bar = 0.5mm.
doi:10.1371/journal.pone.0157079.g008
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Fig 9. Ubr5mt*/mt* limbs and digits appear morphologically normal. Analysis of fore- (A,C, H, I) or hind-paws (B,D,F,G, J-M) of Prx1-Cre (Con) and
Prx1-Cre;Ubr5mt*/mt* (Ubr5mt*/mt*) E15.5 embryos. (A-D) No obvious morphological difference were apparent between Con (A,B) andUbr5mt*/mt* (C,D)
digits. Scale bar = 1mm. (E) Measurement of forelimb digit length, numbered as in (A), revealed a reduction in the average length inUbr5mt*/mt* animals.
However, none of the comparisons between matching digits were statistically significant (p = >0.05). n =6, s.e.m indicated. Statistical analysis by one-way
ANOVA and Tukey multiple comparison tests. (F-M) Histological analysis of haematoxylin (F,H,J,L) and alcian blue (G,I,K,M) stained material. Histology and
morphology of Ubr5mt*/mt* hind- (F,G) or fore-paws (H,I) appeared histologically and morphologically normal, (J-M) as did chondrocyte clusters within the
hind-paw. Scale bar = 250μm (F-I) and 50μM (J-M).
doi:10.1371/journal.pone.0157079.g009
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function. Overall, our data suggested that a reduction in Ihh, rather than Shh, expression
potentially accounted for the observed reduction in HhP activity at E13.5 (see Fig 7).
Due to IHH’s well-established role in regulating bone growth [52, 53] we measured the
length of the Prx1-Cre;Ubr5mt
/mt long bones at E15.5 (Fig 10E and 10F). Similarly to what
was observed in the digits, Prx1-Cre;Ubr5mt
/mt long bones were on average shorter than those
of Ubr5+/+ (WT) or Prx1-Cre (Con) control animals. However, the effects were not statistically
significant. Finally, we chose to examine the E15.5 long bones for morphological defects. As in
the digits, histological analysis of the control and Ubr5mt humerus (Fig 10E–10HJ) and ulna
(Fig 10K–10N) revealed no obvious morphological differences or changes in alcian blue and
alizarin red staining. In conclusion, loss of Ubr5 function correlated with a transient decrease
in Ihh expression, but no obvious or statistically significant limb defects.
Discussion
In conclusion, our in vitro and in vivo findings support the initial hypothesis that UBR5 can
regulate hh ligand family expression and HhP activity. However, we are uncertain as to how
UBR5 influences Hedgehog signalling. One mechanism would involve an indirect route
whereby UBR5 governs the production/maintenance of Hh-ligand producing / Hh-responsive
cells. Such a mechanism could be extremely indirect, with defects occurring early on in devel-
opment only manifesting a molecular or cellular consequence later on. Whereas a more direct
role could involve UBR5 acting cell-autonomously to promote hh ligand mRNA expression
and/or Hh pathway transcriptional outputs. Future efforts will attempt to resolve this
uncertainty.
Our initial in vitro observations supported a cell autonomous role for UBR5 in promoting
RA-mediated Shh expression. Although maximal Shh expression was impaired in UBR5-defi-
cient ES cells, the initial RA-mediated induction was not. Therefore, these results potentially
indicate two distinct phases in RA-mediated Shh expression: (i) an initial UBR5-independent
induction phase and (ii) a subsequent UBR5-regulatable, amplification phase. However, we are
uncertain as to how UBR5 may influence RA-mediated signalling. One possibility resides in
UBR5’s ability to bind [58] the retinoic-acid responsive [59] progesterone receptor (PGR).
Although no evidence exists that PGR induces Shh expression, it can promote Ihh expression
[60, 61].
While our work supported a role for UBR5 in promoting Shh expression in ES cells, it was
not supported by our in vivo studies. At E13.5 Prx1-Cre;UBr5mt
/mt hindlimbs exhibited only
small decreases in Shh expression that were not apparent in the forelimbs. However, significant
decreases in Ihh expression and HhP activity were detected in fore- and hind-limbs at E13.5.
Therefore, in Ubr5mt limbs reduced Ihh expression may have accounted for the reduction in
HhP activity. The transient nature of these effects could indicate (i) a tightly restricted temporal
window of UBR5 action, (ii) functional redundancy and/or (iii) existence of a compensatory/
homeostatic mechanism.
Fig 10. Ubr5mt*/mt* limbs exhibit reduced Ihh expression. (A-B) Ihh and (C,D) Shh qRT-PCR analysis of control
Prx1-Cre (Con) or Prx1-Cre; Ubr5mt*/mt* (Ubr5mt) fore- or hind-limbs at (A,C) E13.5 or E15.5 (B,D) revealed significant
decreases in Ubr5mt limbs versus Con. qRT-PCR values were normalised against β-actin (n = 3, s.e.m indicated).
Statistical analysis by Students t-test. (E,F) Measurement of the length of the indicated long bones in Ubr5+/+ (WT),
Prx1-Cre (Con) or Prx1-Cre;Ubr5mt*/mt* (Ubr5mt*/mt*) animals revealed no statistically significant reductions in length.
Statistical analysis by ANOVA and Tukey multiple comparison test. (G-N) Histological analysis of haematoxylin (G,I,K,M)
and alcian blue + alizarin red (H,J,L,N) stained humerus (G-J) and ulna (K-N) revealed no obvious histological or
morphological differences. Dashed lines = border between chondrocytes and site of primary ossification and
arrowheads = alizarin red positive cortical bone. Scale bar = 100μm.
doi:10.1371/journal.pone.0157079.g010
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Taken together our in vitro and in vivo findings imply that loss ofUbr5 function correlated
with a reduction in hedgehog ligand expression and pathway activity. However, we did not estab-
lish the molecular mechanism by which UBR5 might influence transcription and/or half-life of
hh-family mRNAs. A potential explanation resides in the ability ofDrosophila and mammalian
Hyd/UBR5 to bind Sgg/GSK3β [16, 62] and Ci/GLI [16, 63] as well as influence Sgg-mediated hh
expression [16]. GSK3β’s role as a potent regulator of numerous transcription factors [64], raises
the possibility that it may also regulate the activity of known hedgehog-regulatory transcription
factors such as RUNX2 [65, 66], ATF4 [67], HAND2-TWIST1 [68, 69] and ETV4/5 [70].
While there is currently no evidence to suggest GSK3β regulates Shh or Ihh expression in
mammals, it does bind, phosphorylate and repress GLI proteins [71, 72]. Hyd/UBR5’s ability
to bind Sgg/GSK3β and Ci/GLI therefore provides it with the potential to influence Ci/GLI
activity downstream of any effects on Shh/Ihh ligand expression. Finally, Hyd’s ability to bind
chromatin also provides an alternative means to directly regulate gene expression [63]. Inter-
estingly, the ability of one protein to independently regulate hh ligand expression and GLI
activity is also observed with the Hh-pathway-associated kinase DYRK1B [14]. Together, these
observations support the notion that initiation of Hh signalling (ligand production) and its
response (GLI activity) can be independently co-ordinated by the action of a single protein.
In theUbr5 null embryos, defective Hedgehog signalling may underlie the reported placental
vascular defects [73] and embryonic death [48, 53]. Defective placental function may also explain
our observed midgestation lethality of pCAGG-Cre;Ubr5mt
/mt embryos, but we cannot exclude
an essential role for UBR5 in the embryo proper. The detection of Ubr5 expression within the
pharyngeal arches, a major source for artery development [74] could also provide an alternative/
complementary means for UBR5 to influence embryonic vasculature. Our observation that mid-
gestational loss of one copy of Ubr5 resulted in a reduction in the observed/expected progeny,
suggested that correct Ubr5 gene dosage was required for mid-gestation viability. This is in con-
trast to a lack of any effects on progeny lacking one copy ofUbr5 from conception. We therefore
hypothesise that a gene compensatory mechanism is able to cope with reduced Ubr5 gene dose
from conception, but not in response to an acute decrease in UBR5 function mid-gestation.
The concepts of genetic redundancy and compensation may also explain why we observed
no defect in the embryonic Prx1-Cre;Ubr5mt/mt limbs. A threshold model could also be a poten-
tial explanation, whereby only a certain magnitude of change in Hedgehog signalling would
elicit a morphological defect. Such a model is strongly supported by the normal limb develop-
ment of animals with a 50% reduction in Shh expression [75]. Furthermore, heterozygous
mutant animals of Shh [48], Ihh [76] and Smo [77], also fail to exhibit developmental limb
defects. Therefore, the morphological consequences associated with a reduction in, rather than
complete loss of, a Hedgehog signalling component varies dramatically.
In summary, the generation and validation of a conditional Ubr5mutant mouse provides a
useful tool to address murine development and homeostasis. While our findings further high-
light the importance of UBR5 in embryonic development and ES cell biology, they also rein-
force its potential role in influencing Hedgehog signalling.
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